BioSpace News Archive

Business

Lilly Confirms Date and Conference Call for 2018 Financial Guidance Announcement

Eli Lilly will announce its financial guidance for 2018 on Wednesday, December 13, 2017.

November 20, 2017

·

1 min read

AxoGen Announces Closing of Public Offering of Common Stock

The total net proceeds from the offering for AxoGen are estimated to be approximately $15.4 million

November 20, 2017

·

5 min read

Voyager Therapeutics Announces New Data Presentati

FDA

Cagent Vascular Wins CE Mark for Serranator, a Next Generation Device for Vessel Dilatation in PAD Interventions

The Serranator is one of a family of peripheral artery disease technologies which incorporates proprietary Serration Technology to an angioplasty balloon.

November 20, 2017

·

3 min read

Genetown

T2 Biosystems Announces New T2Bacteria RUO Panel Data Presented at AMP 2017

These data highlight the potential clinical value that may be achieved using the T2Bacteria Panel compared to results from blood culture.

November 20, 2017

·

6 min read

Drug Development

Geron Announces First Patient Dosed in Expanded Part 1 of IMerge Clinical Trial in Myelodysplastic Syndromes

Imetelstat is a telomerase inhibitor initially developed by Geron and exclusively licensed to Janssen Biotech, Inc. (Janssen) on a worldwide basis.

November 20, 2017

·

5 min read

Drug Development

Summit Completes Initial 24 Weeks of Dosing of Ezutromid in Patients With DMD in PhaseOut DMD Clinical Trial

With the achievement of this milestone, Summit continues to expect to report results from this initial 24-week dosing period in the first quarter of 2018.

November 20, 2017

·

6 min read

Beleave Announces $5M Non-Brokered Private Placement of Units

The Company may, as a result, increase the size of the Non-Brokered Offering by up to 20%, for aggregate gross proceeds of approximately $6 million.

November 20, 2017

·

3 min read

Drug Development

Deciphera Pharmaceuticals Reports Data From Ongoing Phase I Clinical Study of DCC-2618 at the 22nd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology

DCC-2618 shows encouraging clinical signal in a patient with glioblastoma multiforme (GBM).

November 20, 2017

·

6 min read

Genetown

Anthera Pharmaceuticals Announces Receipt of Nasdaq Listing Determination Notice and Plans Appeal

Anthera plans to appeal the Staff’s determination and intends to timely request a hearing.

November 20, 2017

·

2 min read

Drug Development

Adocia Reports Topline Results of BioChaperone Glucagon Phase I Study

The main objective of this study was to assess the safety and tolerability of subcutaneous single fixed doses of BioChaperone Glucagon and of GlucaGen HypoKit in subjects with type 1 diabetes.

November 20, 2017

·

5 min read